Cambridge Equities, LP → ImmunityBio, Inc. IBRX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 4.68

135,542,079 shares short · +1.0% vs prior

Other 13D/G Filings on ImmunityBio, Inc.

Filed	Form	Filer	Stake	Shares
2024-01-04	SC	Cambridge Equities, LP	—	—	view →
2023-05-23	SC	Cambridge Equities, LP	—	—	view →
2022-12-07	SC	Cambridge Equities, LP	—	—	view →
2020-12-21	SC	Cambridge Equities, LP	—	—	view →
2020-06-29	SC	Cambridge Equities, LP	—	—	view →
2019-04-01	SC	Cambridge Equities, LP	—	—	view →

Other Filings by Cambridge Equities, LP

Filed	Form	Issuer	Stake	Shares
2024-01-04	SC	ImmunityBio, Inc. IBRX	—	—	view →
2023-05-23	SC	ImmunityBio, Inc. IBRX	—	—	view →
2022-12-07	SC	ImmunityBio, Inc. IBRX	—	—	view →
2020-12-21	SC	NantKwest, Inc. IBRX	—	—	view →
2020-06-29	SC	NantKwest, Inc. IBRX	—	—	view →
2019-04-01	SC	NantKwest, Inc. IBRX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →